Glimepiride Tablets — Class III drug recall D-0312-2024
Ongoing recall by Dr. Reddy's Laboratories, Inc., reported 2024-02-14, distributed nationwide. Misprint on tablet
| Recall number | D-0312-2024 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2024-01-18 |
| Classified | 2024-02-06 |
| Reported by FDA | 2024-02-14 |
| Distributed | Nationwide (US) |
| Quantity | 59,336 bottles |
| NDC | 55111-0320, 55111-0320-01, 55111-0320-05, 55111-0320-30, 55111-0320-78, 55111-0320-79, 55111-0321, 55111-0321-01, 55111-0321-05, 55111-0321-30, 55111-0321-78, 55111-0321-79, 55111-0322, 55111-0322-01, 55111-0322-05, 55111-0322-30, 55111-0322-78, 55111-0322-79 |
| Lot numbers | T2303622, T2303626, T2303627, T2303628, T2303629 |
| Expiration dates | 2026-06 |
Product
Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-01
Reason for recall
Misprint on tablet
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0312-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.